Aphria (TSX:APHA) Soars 35%: Should You Buy This Marijuana Stock Today?

Aphria Inc. (TSX:APHA)(NYSE:APHA) just surprised the market. Is this the time to buy the stock?

Cannabis investors finally received some good news after weeks of downward pressure sent many of Canada’s top marijuana stocks towards 2019 lows.

What happened?

Aphria (TSX:APHA)(NYSE:APHA) became the first major pot producer to report a quarterly profit. The results surprise analysts and attracted a flood of money into the stock, sending the beleaguered marijuana company from $6.90 to above $9.40 per share. Short covering likely provided additional support.

Aphria delivered a revenue gain of 85% compared to the previous quarter. The company sold 5,574 kg of cannabis for revenue of $28.6 million compared to 2,636 kg for revenue of $15.4 million in the previous three months.

Production at the company’s 700,000-square-foot Aphria One site is at full capacity, and the company is moving through the process of getting its adjacent 1.2 million square foot Aphria Diamond facility licensed by Health Canada. Once the additional capacity is online, revenue and profits should continue to improve.

One point to note is that $50 million received from an American company, Green Growth Brands, as part of a settlement in the wake of a failed takeover bid was added in the quarter and contributed to the earnings report. Aphria says an additional $39 million is anticipated in October.

Back on track

Aphria took a big hit late last year when it became the target of a short-seller report that claimed Aphria had overpaid for assets it purchased in Latin America, benefitting people connected to the company.

Aphria’s senior management team initially said the claims were without merit. However, the company founders and the CEO left the firm in January. An investigation by the Ontario Securities Commission led to Aphria being forced to take a $50 million impairment charge on the assets in question.

The stock traded above $21 per share last September and bottomed out around $5 after the short-seller report came out last December. A rebound took it back to $14 in February, but Aphria had drifted consistently lower until the August 2nd bounce.

Should you buy Aphria?

The improvement in sales is a positive sign, and it appears the new management team the board brought in to rebuild the company’s credibility is making good progress. With the new production facility expected to get licensed in the near term, sales and revenue growth should continue into 2020.

I would probably wait for a few days to see if Aphria gives back some of the big gains, but contrarian investors who are positive on the sector might want to start nibbling on the stock once the euphoria settles.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »